Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use Of Peripheral Blood Stem Cells For Allogeneic Transplantation

NCT00008216 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00008216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use Of Peripheral Blood Stem Cells For Allogeneic Transplantation
Lead sponsor
Columbia University
Phase
Observational
Overall status
Terminated
Start date
July 31, 1996
Completion date
January 31, 2009
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult langerhans cell histiocytosis, childhood langerhans cell histiocytosis, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms